Associated Papers
BRAF mutations and targeted therapy in unclassified pericytic tumors: insights from genetic analysis and clinical response.
Golan H et al.
Bmc Cancer, 2025
41174508 (PubMed )
Supplement: 12885_2025_14595_MOESM2_ESM.xls › high-confidence_variants__2_
Somatic Mutations Alter Interleukin Signaling Pathways in Grade II Invasive Breast Cancer Patients: An Egyptian Experience.
Nassar A et al.
Current Issues in Molecular Biology, 2022
36547062 (PubMed )
Supplement: cimb-44-00401-s001.zip › supplementary_2.xlsx › CCP_ALL_source
Calibration-free NGS quantitation of mutations below 0.01% VAF.
Dai P et al.
Nature Communications, 2021
34675197 (PubMed )
Supplement: 41467_2021_26308_MOESM6_ESM.xlsx › Supplementary_Data_5
Genomics of lethal prostate cancer at diagnosis and castration resistance.
Mateo J et al.
The Journal of Clinical Investigation, 2020
31874108 (PubMed )
Supplement: jci-130-132031-s100.xlsx › Sheet1
Search for mutations in signaling pathways in head and neck squamous cell carcinoma.
De Carvalho TG et al.
Oncology Reports, 2013
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.
Flex E et al.
The Journal of Experimental Medicine, 2008
18362173 (PubMed )
Supplement: jexpmed_jem.20072182_5.pdf
Select a paper to view details